E N Kraybill, J L Sever, G B Avery, N Movassaghi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Agranulocytosis/chemically inducedCytarabine/administration & dosageCytarabine/adverse effectsCytarabine/pharmacologyCytarabine/therapeutic useCytomegalovirus/drug effectsCytomegalovirus Infections/congenitalCytomegalovirus Infections/drug therapyFemaleHumansInfantInfant, NewbornMaleThrombocytopenia/chemically inducedVomiting
Substances: See more » Cytarabine
Year: 1972 PMID: 4334177 DOI: 10.1016/s0022-3476(72)80514-6
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406